Osteomalacia with bone marrow fibrosis due to severe vitamin D deficiency after a gastrointestinal bypass operation for severe obesity

Endocrine Practice

Volumn 15, Issue 6, 2009, Pages 528-533

  Al Shoha, Ahmad ^a   Qiu, Shijing ^a   Palnitkar, Saroj ^a   Rao, D Sudhaker ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CARBONATE; ERGOCALCIFEROL;

ADULT; ARTHRITIS; ARTICLE; BODY POSTURE; BONE BIOPSY; BONE DENSITY; BONE PAIN; CASE REPORT; FEMALE; FUNCTIONAL STATUS; GAIT DISORDER; GENERAL CONDITION IMPROVEMENT; GOUT; HUMAN; HUMAN TISSUE; MALE; MORBID OBESITY; MORPHOMETRICS; MUSCLE WEAKNESS; MYELOFIBROSIS; OSTEOMALACIA; OSTEOPOROSIS; STOMACH BYPASS; THERAPY EFFECT; TREATMENT RESPONSE; VITAMIN D DEFICIENCY; WALKING DIFFICULTY; BILIOPANCREATIC BYPASS; BIOPSY; BONE; MIDDLE AGED; MYELOID METAPLASIA; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; BILIOPANCREATIC DIVERSION; BIOPSY; BONE AND BONES; ERGOCALCIFEROLS; FEMALE; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; OSTEOMALACIA; PRIMARY MYELOFIBROSIS; RETROSPECTIVE STUDIES; VITAMIN D DEFICIENCY;

EID: 75549091797     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP09050.ORR     Document Type: Article

References (40)

1. Ogden CL, Carroll MD, McDowell MA, Flegal KM. Obesity among adults in the United States - no statistically significant change since 2003-2004. November 2007. http://www.cdc.gov/nchs/data/databriefs/db01.pdf. Accessed for verification May 16, 2009.
2. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
3. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356:2176-2183.
4. Haslam DW, James WP. Obesity. Lancet. 1980;366: 1197-1209.
5. Yanovski SZ, Yanovski JA. Obesity. N Engl J Med. 2002; 346:591-602.
6. Sjöström L, Lindroos AK, Peltonen M, et al (Swedish Obese Subjects Study Scientific Group). Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693.
7. Balsiger BM, Murr MM, Poggio JL, Sarr MG. Bariatric surgery: surgery for weight control in patients with morbid obesity. Med Clin North Am. 2000;84:477-489.
8. Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA. 2002;288:2793-2796.
9. Brolin RE. Gastric bypass. Surg Clin North Am. 2001;81: 1077-1095.
10. Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg. 2004;14:1157-1164.
11. Steinbrook R. Surgery for severe obesity. N Engl J Med. 2004;350:1075-1079.
12. Halverson JD, Wise L, Wazna MF, Ballinger WF. Jejunoileal bypass for morbid obesity: a critical appraisal. Am J Med. 1978;64:461-475.
13. Deitel M, Shahi B, Anand PK, Deitel FH, Cardineli DL. Long-term outcome in a series of jejunoileal bypass patients. Obes Surg. 1993;3:247-252.
14. Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery. 1996;119: 261-268.
15. Scopinaro N, Marinari GM, Camerini G. Laparoscopic standard biliopancreatic diversion: technique and preliminary results. Obes Surg. 2002;12:241-244.
16. Shaker JL, Norton AJ, Woods MF, Fallon MD, Findling JW. Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteoporos Int. 1991;1:177-181.
17. Crowley LV, Seay J, Mullin G. Late effects of gastric bypass for obesity. Am J Gastroenterol. 1984;79:850-860.
18. Parfitt AM, Miller MJ, Frame B, et al. Metabolic bone disease after intestinal bypass for treatment of obesity. Ann Intern Med. 1978;89:193-199.
19. Parfitt AM, Pødenphant J, Villanueva AR, Frame B. Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone. 1985;6:211-220.
20. Honasoge M, Rao DS. Metabolic bone disease in gastrointestinal, hepatobiliary, and pancreatic disorders and total parenteral nutrition. Curr Opin Rheumatol. 1995;7:249-254.
21. Collazo-Clavell ML, Jimenez A, Hodgson SF, Sarr MG. Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract. 2004;10:195-198.
22. Goldner WS, O'Dorisio TM, Dillon JS, Mason EE. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg. 2002;12:685-692.
23. De Prisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci. 2005;329:57-61.
24. Rao DS. Practical approach to bone biopsy. In: Recker R, ed. Bone Histomorphometry: Techniques and Interpretations. Boca Raton, FL: CRC Press, 1983: 3-11.
25. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units; report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2: 595-610.
26. Rao DS. Perspective on assessment of vitamin D nutrition. J Clin Densitom. 1999;2:457-464.
27. Kleerekoper M, Nelson DA, Peterson EL, et al. Reference data for bone mass, calciotropic hormones, and biochemical markers of bone remodeling in older (55-75) postmenopausal white and black women. J Bone Miner Res. 1994;9:1267-1276.
28. Rao DS, Villanueva AR, Mathews M, et al. Histologic evolution of vitamin D depletion in patients with intestinal malabsorption or dietary deficiency. In: Frame B, Potts JT Jr, eds. Clinical Disorders of Bone and Mineral Metabolism. Amsterdam, The Netherlands: Excerpta Medica, 1983: 224-226.
29. Basha B, Rao DS, Han ZH, Parfitt AM. Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption. Am J Med. 2000;108:296-300.
30. Parfitt AM, Rao DS, Stanciu J, Villanueva AR, Kleerekoper M, Frame B. Irreversible bone loss in osteomalacia: comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment. J Clin Invest. 1985;76:2403-2412.
31. Carlin AM, Rao DS, Meslemani AM, et al. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis. 2006;2: 98-103.
32. Stéphan JL, Galambrun C, Dutour A, Freycon F. Myelofibrosis: an unusual presentation of vitamin D-deficient rickets. Eur J Pediatr. 1999;158:828-829.
33. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med. 1993;328:171-175.
34. Bhadada SK, Bhansali A, Ahluwalia J, Chanukya GV, Behera A, Dutta P. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy. Clin Endocrinol (Oxf). 2009; 70:527-532.
35. Heaney RP. Vitamin D: how much do we need, and how much is too much? Osteoporos Int. 2000;11:553-555.
36. American Association of Clinical Endocrinologists Osteoporosis Task Force. American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract. 2001;7:293-312.
37. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab. 1995;80:1052-1058.
38. Jackson RD, LaCroix AZ, Gass M, et al (Women's Health Initiative Investigators). Calcium plus vitamin D supplementation and the risk of fractures [published correction appears in N Engl J Med. 2006;354:1102]. N Engl J Med. 2006;354:669-683.
39. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004;291:1999-2006.
40. Carlin AM, Yager KM, Rao DS. Vitamin D depletion impairs hypertension resolution after Roux-en-Y gastric bypass. Am J Surg. 2008;195:349-352.